The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2020
Filed:
Dec. 18, 2018
University of Cincinnati, Cincinnati, OH (US);
Government of the United States As Represented BY the Secretary of the Air Force, Wright-Patterson AFB, OH (US);
Daniel J. Hassett, Cincinnati, OH (US);
Thomas J. Lamkin, Cincinnati, OH (US);
Warunya Panmanee, Cincinnati, OH (US);
Deborah E. Taylor, Cincinnati, OH (US);
Chloe J. A. Shea, Cincinnati, OH (US);
University of Cincinnati, Cincinnati, OH (US);
Government of the United States as Represented by the Secretary of the Air Force, Wright-Patterson AFB, OH (US);
Abstract
A high through-put screening method for identifying agents effective for inhibiting biofilm formation and/or killing established biofilm are disclosed. The method includes three tiers, and each tier includes three specific biological process assays. The tier levels are a primary screen, a confirmation screen, and a dose-response screen, and the biological process assays include assays for total bacterial growth, bacterial metabolic activity, and biofilm formation. The series of assays may be run once or more than once at each tier. A library of compounds is subject to tier A and only compounds meeting a primary parameter advance to tier B, and only tier B compounds meeting a confirmation parameter advance to tier C, and only tier C compounds meeting a dose-response parameter are identified as putative agents effective for inhibiting and/or eradicating a biofilm, further wherein the assays are conducted for each compound subject to the respective tier. The method is effective and validated for identifying agents which inhibit and/or kill, andbiofilms. Agents identified according to the high through-put screen and validated in follow-up experiments as effective for inhibiting and/or killing bacterial biofilms are also disclosed.